Myomo Announces First Quarter Financial Results Release Date of May 8, 2024

Myomo, Inc., a wearable medical robotics company specializing in providing increased functionality for individuals with neurological disorders and upper-limb paralysis, has announced that it will be releasing its financial results for the first quarter ending on March 31, 2024, on May 8, 2024. The company will be hosting a conference call on the same day at 4:30 p.m. ET, featuring remarks from Paul R. Gudonis, chairman and CEO, and David Henry, CFO.

Participants are encouraged to pre-register for the conference call to receive a conference passcode and unique PIN for immediate access. Those without internet access can dial in using the provided numbers. A webcast of the call will also be available on Myomo’s Investor Relations page.

Myomo, Inc. is known for its MyoPro product line, which offers improved arm and hand function for individuals with conditions such as stroke, brachial plexus injury, spinal cord injury, ALS, and other neuromuscular diseases. The MyoPro device is designed to support and restore function to weakened or paralyzed arms by sensing the patient’s own EMG signals through non-invasive sensors.

The company’s innovative technology has enabled many individuals to regain the ability to perform daily activities independently, reducing the need for extensive care. Myomo is headquartered in Boston, Massachusetts, with a presence across the U.S. and internationally.

For more information on Myomo, Inc. and its upcoming financial report, visit their website at www.myomo.com.